Buy Ephenidine for sale online from USA vendor
Table of Contents
-
Introduction
- History and Culture
- Chemistry
- Pharmacology
-
Dosage
- Threshold
- Light
- Common
- Strong
- Heavy
-
Physical Effects
- Stimulation
- Tactile Disconnection
- Spatial Disorientation
- Pain Relief
- Cough Suppression
- Appetite Suppression
- Nausea
- Changes in Felt Gravity
- Spontaneous Physical Sensations
- Tactile Suppression
- Motor Control Loss
- Perception of Bodily Lightness
- Gait Alteration
- Physical Autonomy
- Increased Heart Rate
- Orgasm Suppression
-
Visual Effects
- Suppression
- Visual Disconnection
- Visual Acuity Suppression
- Double Vision
- Pattern Recognition Suppression
- Frame Rate Suppression
- Distortions
- Hallucinatory States
-
Cognitive Effects
- Thought Acceleration and Deceleration
- Depersonalization and Derealization
- Dream Potentiation
- Consciousness Disconnection
- Memory Suppression
- Ego Death and Ego Inflation
- Motivation Enhancement and Analysis Suppression
- Time Distortion and Cognitive Euphoria
-
Auditory Effects
- Auditory Enhancement
- Auditory Suppression
- Auditory Distortion
- Auditory Hallucination
-
Transpersonal Effects
- Existential Self-Realization
- Profound Insights
-
Toxicity and Harm Potential
-
Tolerance and Addiction Potential
-
Dangerous Interactions
-
Legal Status
Exploring Ephenidine: A Novel Dissociative Substance
Understanding Ephenidine
Ephenidine, also recognized as NEDPA and EPE, belongs to the diarylethylamine class, constituting a lesser-known yet significant member. Structurally akin to diphenidine and methoxphenidine, it operates as an NMDA receptor antagonist, influencing neural signaling pathways.
Pharmacological Background
Ephenidine, along with its related compounds, has garnered attention for its potential therapeutic applications in treating neurotoxic injuries. However, its recreational utilization gained traction post the 2013 U.K. arylcyclohexylamine ban. Initially, it emerged within the online research chemical market, often promoted as an alternative to methoxetamine (MXE). Despite such assertions, users reported distinctive effects, setting it apart from its counterparts.
Effects and Risks
Ephenidine induces an array of effects ranging from sedation and hallucinations to anesthesia and dissociative states, colloquially termed "dissociative anesthesia." Yet, despite its allure, a dearth of substantial data prevails concerning its pharmacology, metabolism, and toxicity.
Safety Concerns
The scant history of human usage underscores the need for caution. Abuse of diarylethylamines, including ephenidine, has been associated with both fatal and non-fatal overdoses. Furthermore, anecdotal evidence suggests potential risks distinct from those posed by traditional dissociatives. Thus, prudent harm reduction practices are imperative for individuals considering ephenidine consumption.
Unveiling Ephenidine: A Designer Drug
History and Culture
Ephenidine falls under the category of designer drugs, which mimic the functional and structural characteristics of commonly used illicit substances to evade government regulations. This designation highlights its emergence within the realm of circumventing legal frameworks.
Chemistry
Belonging to the diarylethylamine class, ephenidine comprises a substituted phenethylamine skeleton with an additional phenyl ring attached to Rα. An ethyl chain binds to the terminal amine RN of the phenethylamine structure. While ephenidine shares structural similarities with diphenidine and MXP, it diverges as it lacks a piperidine dissociative component, setting it apart from its counterparts.
Pharmacology
Ephenidine operates as an antagonist of the NMDA receptor (Ki = 66.4 nM), a significant receptor subtype for glutamate, the primary excitatory neurotransmitter in the central nervous system (CNS). Blocking NMDA channels induces various effects ranging from anesthesia to immobilization, with higher doses potentially leading to experiences akin to the "K-hole."
Moreover, ephenidine exhibits weaker affinity for dopamine and norepinephrine transporters (379 nM and 841 nM, respectively), alongside binding sites for σ1R (629 nM) and σ2R (722 nM).
Subjective Effects
Ephenidine's subjective effects vary based on administration method. Vaporization or smoking reportedly results in a quicker onset and shorter half-life, albeit with suspected carcinogenic properties when exposed to excessive heat. User reports suggest that vaporization or plugging may require as low as 20% of the common oral dose for a similar effect.
Disclaimer: The effects mentioned above are sourced from the Subjective Effect Index (SEI), which relies on anecdotal user reports and personal analyses of contributors. Thus, they should be interpreted with caution. Additionally, these effects may not manifest consistently, with higher doses posing risks of adverse effects such as addiction, severe injury, or even death.
Understanding Dosage of Ephenidine
Threshold
The threshold dosage for ephenidine is reported to be around 30 mg. At this level, users may begin to perceive subtle effects, marking the onset of the substance's influence.
Light Dosing
Light doses of ephenidine typically range from 30 to 70 mg. Within this dosage range, users may experience mild to moderate effects, often characterized by slight alterations in perception and mood.
Common Dosing
A common dose of ephenidine falls within the range of 70 to 100 mg. At this level, users can expect more pronounced effects, including significant alterations in perception, mood, and cognition.
Strong Dosing
Strong doses of ephenidine typically range from 100 to 150 mg. Within this range, users may experience intense and potentially overwhelming effects, requiring a controlled and comfortable environment for navigation.
Heavy Dosing
Heavy doses of ephenidine exceed 150 mg and can induce profound and potentially incapacitating effects. Such doses should be approached with extreme caution, as they may pose significant risks to both physical and psychological well-being.
Understanding the Physical Effects of Ephenidine
Stimulation
Ephenidine induces stimulating effects, albeit less intense than its counterparts diphenidine or methoxphenidine, particularly at lower doses.
Tactile Disconnection
Users may experience a disconnect from tactile sensations, leading to altered perceptions of touch and sensation within the body.
Spatial Disorientation
Ephenidine can cause spatial disorientation, making it challenging for users to maintain a sense of direction or spatial awareness.
Pain Relief
Anecdotal reports suggest ephenidine may possess analgesic properties, providing relief from physical discomfort.
Cough Suppression
Users may experience suppression of cough reflexes, leading to decreased coughing.
Appetite Suppression
Ephenidine can lead to a reduction in appetite, potentially resulting in decreased food intake.
Nausea
Although inconsistently reported, some users may experience nausea, particularly within similar dosage ranges.
Changes in Felt Gravity
Users may perceive alterations in the sense of gravity, leading to sensations of weightlessness or heaviness.
Spontaneous Physical Sensations
Ephenidine induces a soft and pleasurable tingling sensation, often motionless and enveloping the body with no specific location.
Tactile Suppression
This effect partially or entirely suppresses the sense of touch, resulting in feelings of numbness in the extremities, contributing to the substance's anesthetic properties.
Motor Control Loss
Loss of gross and fine motor control, balance, and coordination is common with ephenidine, especially at higher doses, necessitating a seated position to prevent injury.
Perception of Bodily Lightness
Ephenidine creates a sensation of bodily lightness, making movements feel effortless and encouraging physical activities at lower to moderate doses.
Gait Alteration
Movement, such as walking, may be perceived as automated and robotic under the influence of ephenidine.
Physical Autonomy
Users may experience a sense of physical autonomy, feeling detached from their body and surroundings.
Increased Heart Rate
Ephenidine can lead to an increase in heart rate, potentially contributing to cardiovascular effects.
Orgasm Suppression
Some users may experience suppression of orgasmic sensations while under the influence of ephenidine.
Visual Effects
Visual effects induced by ephenidine include:
Suppression
Ephenidine may suppress visual perception, leading to alterations in vision.
Visual Disconnection
At higher doses, users may experience dissociative visual effects, akin to the renowned "k-hole," characterized by voids, spaces, and structural distortions.
Visual Acuity Suppression
Moderate to heavy doses of ephenidine may lead to suppression of visual acuity, making tasks like reading challenging without closing one eye.
Double Vision
Double vision may occur at moderate to heavy dosages, impairing visual perception and making reading impossible without corrective measures.
Pattern Recognition Suppression
Higher dosages of ephenidine may inhibit pattern recognition, making it difficult for users to interpret visual data.
Frame Rate Suppression
Users may perceive a reduction in visual frame rate, leading to a sense of visual sluggishness or delay.
Distortions
Ephenidine induces various visual distortions, including drifting, morphing, and geometric alterations in the visual field.
Hallucinatory States
At high doses, ephenidine can induce a full range of hallucinatory states, albeit less consistently than other psychedelics, including:
- Internal hallucinations: Autonomous entities, settings, and scenarios may manifest, albeit less frequently than with classical psychedelics.
- Cognitive Effects
The cognitive effects of ephenidine include:
- Thought acceleration and deceleration
- Depersonalization and derealization
- Dream potentiation
- Consciousness disconnection
- Memory suppression
- Ego death and ego inflation
- Motivation enhancement and analysis suppression
- Time distortion and cognitive euphoria
Auditory Effects
Ephenidine may induce auditory effects such as enhancement, suppression, distortion, and even hallucination.
Transpersonal Effects
Users may experience existential self-realization and profound insights into their existence while under the influence of ephenidine.
Toxicity and Harm Potential
The toxicity and long-term health effects of ephenidine remain largely unstudied, given its limited history of human usage. Anecdotal reports suggest minimal negative effects at low to moderate doses, but caution and harm reduction practices are recommended.
Tolerance and Addiction Potential
Chronic use of ephenidine can lead to moderate addiction potential and psychological dependence. Tolerance develops with prolonged use, requiring higher doses to achieve the same effects and presenting cross-tolerance with other dissociatives.
Dangerous Interactions
Combining ephenidine with other psychoactive substances, particularly stimulants or depressants, can pose risks of adverse psychological reactions, respiratory depression, and even death. Conduct thorough research before combining substances to ensure safety.
Legal Status
Ephenidine's legal status varies by country, with some nations classifying it as a controlled substance due to its structural similarities to banned opioids or derivatives of phenylethylamine.
- Canada: Ephenidine and its analogues are categorized as Schedule I controlled substances, carrying penalties of up to seven years imprisonment for possession without legal authorization.
- Germany: Regulated under the New Psychoactive Substances Act (NpSG) as a derivative of 2-Phenylethylamine.
- Sweden: Classified as a scheduled substance following a recommendation by Sweden's public health agency.
- Switzerland: Controlled under Verzeichnis E.
- Turkey: Classified as a drug and illegal to possess, produce, supply, or import.
- United Kingdom: Illegal to produce, supply, or import under the Psychoactive Substance Act.
- United States: Potentially considered a positional isomer of SPA (lefetamine), a Schedule IV drug, though prosecution under this clause is rare.
It's important to note that legal status can change, and individuals should verify the current legal standing of ephenidine in their jurisdiction before any use or distribution.
By understanding the physical effects, toxicity, addiction potential, and legal status of ephenidine, users can make informed decisions and prioritize safety when engaging with this substance.
Frequently Asked Questions (FAQ)
-
Is ephenidine legal?
- The legal status of ephenidine varies by country, with some nations classifying it as a controlled substance while others may not have specific regulations in place. It's crucial to verify the legal standing of ephenidine in your jurisdiction before use.
-
What are the common physical effects of ephenidine?
- Common physical effects include stimulation, tactile disconnection, spatial disorientation, pain relief, cough suppression, appetite suppression, and changes in felt gravity, among others.
-
Are there risks associated with ephenidine use?
- While ephenidine's toxicity and long-term health effects remain largely unstudied, anecdotal reports suggest minimal negative effects at low to moderate doses. However, caution and harm reduction practices are recommended due to the potential for addiction and dangerous interactions with other substances.
-
How should ephenidine be dosed?
- Dosage recommendations vary depending on individual tolerance and desired effects. Threshold doses start around 30 mg, with light doses ranging from 30 to 70 mg, common doses from 70 to 100 mg, strong doses from 100 to 150 mg, and heavy doses exceeding 150 mg.
-
What are the visual effects of ephenidine?
- Visual effects may include suppression, visual disconnection, double vision, distortions, and hallucinatory states. These effects can vary depending on dosage and individual sensitivity.
-
Is ephenidine addictive?
- Chronic use of ephenidine can lead to moderate addiction potential and psychological dependence. Tolerance develops with prolonged use, necessitating higher doses to achieve the same effects.
-
Are there any dangerous interactions with ephenidine?
- Combining ephenidine with other psychoactive substances, particularly stimulants or depressants, can pose risks of adverse psychological reactions, respiratory depression, and even death. It's essential to conduct thorough research before combining substances to ensure safety.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics